ArticleCase reports in cardiology2020

Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience.

Álvaro Herrera-Escandón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.